$27.610
+3.153 (+11.42%)Zum Schluss
VOYG-News
VOYG-Events
Voyager Technologies Signs Contract with Interstellar Lab
Voyager Technologies executed a mission management contract with Interstellar Lab to host BioPod EDEN aboard the International Space Station, ISS. Under the contract, Voyager Technologies will provide end-to-end payload hosting for the middeck locker-class payload, including design and safety review support across NASA's review phases; engineering and technical support; assembly, integration and testing; concept of operations and on-orbit activities; and return of the payload to the customer. The specific hosting accommodation aboard the ISS will be determined by NASA. The payload runs mostly autonomously once installed reducing crew time and at the end of the science mission a crew member will select plant samples and place them in cold storage at minus 4 degrees Fahrenheit for the trip home.
Voyager Technologies Completes Acceptance Testing for Griffin Mission One
Voyager Technologies announced Griffin Mission One successfully completed acceptance testing, a critical milestone on the path to its targeted launch to the Moon in late 2026. "Griffin-1 marks a turning point for commercial lunar infrastructure," said Dylan Taylor, Chairman and CEO, Voyager. "We are an enabler in building the transportation layer for the lunar economy: the logistics, access and systems that make sustained operations on the Moon possible. When Griffin touches down, it will be the largest commercial payload delivery in lunar history. The team has put years of work into this mission, and we are focused on getting Griffin to the Moon and putting that capability to work."
Voyager Technologies Appoints Patrick Yarborough as VP of Investor Relations
Voyager Technologies appointed Patrick Yarborough as vice president, Investor Relations, bringing more than a decade of capital markets, investor communications and corporate development experience to the company. Yarborough most recently served as the strategic transactions lead at Lockheed Martin Space, where he focused on the evolving space and defense technology landscape, translating corporate strategy into actionable inorganic growth opportunities and transaction execution through financial and market analyses.
Voyager Technologies Signs Contract to Manage Biopolymer Cancer Implant Experiment
Voyager Technologies signed a contract with the Center for the Advancement of Science in Space to manage Symphony Biosciences' biopolymer cancer implant experiment aboard the International Space Station, ISS. The contract underscores the continued demand for access to low-Earth orbit for biopharmaceutical research. Under the contract, Voyager will adapt Symphony Biosciences' sample hardware to station equipment, ensure the clearing of NASA safety reviews and manage integration and stowage for launch.
Voyager Technologies Awarded $22.4M R&D Agreement
Voyager Technologies announced the award of a $22.4M Other Transaction Agreement, OTA, with the Strategic Capabilities Office, SCO, from the Department of War, DoW, for a Research and Development, R&D, effort to prototype next-generation satellite deployment systems. The effort's ultimate objective is to transition new technology and capability to the U.S. Space Force. Under the OTA, Voyager will deliver prototype, but flight-ready small sat dispensers purpose-built to extract new mission value from space launches that otherwise leave payload capacity on the table.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.